Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hung-Chih Yang

Showing results (21-30 of 144) with videos related to

Pageof 15
Sort By:
Evidence-Based Complementary and Alternative Medicine : Ecam|May 9, 2013
Catechins and Sialic Acid Attenuate Helicobacter pylori-Triggered Epithelial Caspase-1 Activity and Eradicate Helicobacter pylori InfectionJyh-Chin Yang, Hung-Chih Yang, Chia-Tung Shun, et al.
Nature Protocols|November 7, 2014
A primary CD4(+) T cell model of HIV-1 latency established after activation through the T cell receptor and subsequent return to quiescenceMichelle Kim, Nina N Hosmane, C Korin Bullen, et al.
Journal for Immunotherapy of Cancer|March 26, 2025
Differential regulation of calcium-NFAT signaling pathway by Akt isoforms: unraveling effector dynamics and exhaustion of cytotoxic T lymphocytes in tumor microenvironmentWen-Ling Chen, Yong-Lin Chang, Su-Fang Lin, et al.
Journal of the American Academy of Dermatology|March 25, 2015
Liver injury in patients with DRESS: A clinical study of 72 casesI-Chun Lin, Hung-Chih Yang, Carol Strong, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 6, 2020
Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in TaiwanHau-Jyun Su, Jia-Horng Kao, Tai-Chung Tseng, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|July 20, 2025
Interleukin 27 (IL-27) productions in the liver microenvironment confer an immunosuppressive role and enhance hepatitis B viral persistenceHsiu-Jung Liao, Lin-Ping Cheng, Yu-Ching Hsieh, et al.
Hepatology (Baltimore, Md.)|September 1, 2017
Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis BGeorge V Papatheodoridis, Spilios Manolakopoulos, Tung-Hung Su, et al.
Journal of Virology|April 28, 2006
Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapyJustin R Bailey, Kara G Lassen, Hung-Chih Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 9, 2016
Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathwayWei-Liang Liu, Hung-Chih Yang, Ching-Sheng Hsu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 23, 2023
Immunogenicity and safety of heterologous booster with protein-based COVID-19 vaccine (NVX-CoV2373) in healthy adults: A comparative analysis with mRNA vaccinesWang-Huei Sheng, Pin-Hung Lin, Yu-Chen Cheng, et al.
Pageof 15

Showing results (21-30 of 144) with videos related to

Sort By:
Pageof 15
Evidence-Based Complementary and Alternative Medicine : Ecam|May 9, 2013
Catechins and Sialic Acid Attenuate Helicobacter pylori-Triggered Epithelial Caspase-1 Activity and Eradicate Helicobacter pylori InfectionJyh-Chin Yang, Hung-Chih Yang, Chia-Tung Shun, et al.
Nature Protocols|November 7, 2014
A primary CD4(+) T cell model of HIV-1 latency established after activation through the T cell receptor and subsequent return to quiescenceMichelle Kim, Nina N Hosmane, C Korin Bullen, et al.
Journal for Immunotherapy of Cancer|March 26, 2025
Differential regulation of calcium-NFAT signaling pathway by Akt isoforms: unraveling effector dynamics and exhaustion of cytotoxic T lymphocytes in tumor microenvironmentWen-Ling Chen, Yong-Lin Chang, Su-Fang Lin, et al.
Journal of the American Academy of Dermatology|March 25, 2015
Liver injury in patients with DRESS: A clinical study of 72 casesI-Chun Lin, Hung-Chih Yang, Carol Strong, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 6, 2020
Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in TaiwanHau-Jyun Su, Jia-Horng Kao, Tai-Chung Tseng, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|July 20, 2025
Interleukin 27 (IL-27) productions in the liver microenvironment confer an immunosuppressive role and enhance hepatitis B viral persistenceHsiu-Jung Liao, Lin-Ping Cheng, Yu-Ching Hsieh, et al.
Hepatology (Baltimore, Md.)|September 1, 2017
Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis BGeorge V Papatheodoridis, Spilios Manolakopoulos, Tung-Hung Su, et al.
Journal of Virology|April 28, 2006
Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapyJustin R Bailey, Kara G Lassen, Hung-Chih Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 9, 2016
Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathwayWei-Liang Liu, Hung-Chih Yang, Ching-Sheng Hsu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 23, 2023
Immunogenicity and safety of heterologous booster with protein-based COVID-19 vaccine (NVX-CoV2373) in healthy adults: A comparative analysis with mRNA vaccinesWang-Huei Sheng, Pin-Hung Lin, Yu-Chen Cheng, et al.
Pageof 15